Severe and/or prolonged COVID-19 in hematologic diseases: clinical implications before and during the omicron era

Akinao Okamoto, Masahiro Yoshida, Senji Kasahara, Takahide Ara, Kazutaka Ozeki, Takanobu Morishita, Daisuke Ikeda, Minoru Kanaya, Tomohiro Kajiguchi, Yasuhiro Suzuki, Shingo Kurahashi, Tomohiro Horio, Yoshiaki Marumo, Tatsuo Oyake, Shigeki Saito, Hitomi Sawa, Shun-ichi Kimura, Takahiro Nishiyama, Eisei Kondo, Junji Hiraga, Hiroki Hosoi, Yasufumi Masaki, Yoshiko Atsuta, Hideyuki Yamamoto, Takahiko Miyama, Naoe Goto, Chisako Iriyama, Keichiro Mihara, Yoshihiro Inamoto, Akihiro Tomita

Open source

DOI: 10.3389/fonc.2025.1687204
Published: 2025-11-05
Container: Frontiers in Oncology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2025.1687204,
  title = {Severe and/or prolonged COVID-19 in hematologic diseases: clinical implications before and during the omicron era},
  author = {Akinao Okamoto and Masahiro Yoshida and Senji Kasahara and Takahide Ara and Kazutaka Ozeki and Takanobu Morishita and Daisuke Ikeda and Minoru Kanaya and Tomohiro Kajiguchi and Yasuhiro Suzuki and Shingo Kurahashi and Tomohiro Horio and Yoshiaki Marumo and Tatsuo Oyake and Shigeki Saito and Hitomi Sawa and Shun-ichi Kimura and Takahiro Nishiyama and Eisei Kondo and Junji Hiraga and Hiroki Hosoi and Yasufumi Masaki and Yoshiko Atsuta and Hideyuki Yamamoto and Takahiko Miyama and Naoe Goto and Chisako Iriyama and Keichiro Mihara and Yoshihiro Inamoto and Akihiro Tomita},
  year = {2025},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2025.1687204},
  url = {https://doi.org/10.3389/fonc.2025.1687204}
}

RIS

TY  - JOUR
TI  - Severe and/or prolonged COVID-19 in hematologic diseases: clinical implications before and during the omicron era
AU  - Akinao Okamoto
AU  - Masahiro Yoshida
AU  - Senji Kasahara
AU  - Takahide Ara
AU  - Kazutaka Ozeki
AU  - Takanobu Morishita
AU  - Daisuke Ikeda
AU  - Minoru Kanaya
AU  - Tomohiro Kajiguchi
AU  - Yasuhiro Suzuki
AU  - Shingo Kurahashi
AU  - Tomohiro Horio
AU  - Yoshiaki Marumo
AU  - Tatsuo Oyake
AU  - Shigeki Saito
AU  - Hitomi Sawa
AU  - Shun-ichi Kimura
AU  - Takahiro Nishiyama
AU  - Eisei Kondo
AU  - Junji Hiraga
AU  - Hiroki Hosoi
AU  - Yasufumi Masaki
AU  - Yoshiko Atsuta
AU  - Hideyuki Yamamoto
AU  - Takahiko Miyama
AU  - Naoe Goto
AU  - Chisako Iriyama
AU  - Keichiro Mihara
AU  - Yoshihiro Inamoto
AU  - Akihiro Tomita
PY  - 2025
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2025.1687204
UR  - https://doi.org/10.3389/fonc.2025.1687204
ER  -

APA

Okamoto, A., Yoshida, M., Kasahara, S., Ara, T., Ozeki, K., Morishita, T., Ikeda, D., Kanaya, M., Kajiguchi, T., Suzuki, Y., Kurahashi, S., Horio, T., Marumo, Y., Oyake, T., Saito, S., Sawa, H., Kimura, S., Nishiyama, T., Kondo, E., Hiraga, J., Hosoi, H., Masaki, Y., Atsuta, Y., Yamamoto, H., Miyama, T., Goto, N., Iriyama, C., Mihara, K., Inamoto, Y., & Tomita, A. (2025). Severe and/or prolonged COVID-19 in hematologic diseases: clinical implications before and during the omicron era. Frontiers in Oncology. https://doi.org/10.3389/fonc.2025.1687204

Source records

crossref · retrieved 2026-09-27T14:38:22.948Z